These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8192719)

  • 1. Prevention and treatment of Pneumocystis pneumonia.
    Min DI; Noormohamed SE
    N Engl J Med; 1993 May; 328(21):1569. PubMed ID: 8192719
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and treatment of Pneumocystis pneumonia.
    Ong EL; Mandal BK
    N Engl J Med; 1993 May; 328(21):1569. PubMed ID: 8479504
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole prophylaxis of Pneumocystis carinii pneumonia in infants.
    Mueller BU; Pizzo PA
    Pediatr Infect Dis J; 1992 Dec; 11(12):1072-3. PubMed ID: 1461709
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
    N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of pneumocystis pneumonia.
    Masur H
    N Engl J Med; 1992 Dec; 327(26):1853-60. PubMed ID: 1448123
    [No Abstract]   [Full Text] [Related]  

  • 6. Less frequent TMP-SMX is effective.
    AIDS Patient Care STDS; 2000 Feb; 14(2):104. PubMed ID: 10743528
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
    Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis against Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus.
    CDR (Lond Engl Wkly); 1991 Apr; 1(15):65. PubMed ID: 1669802
    [No Abstract]   [Full Text] [Related]  

  • 9. Pneumocystis jiroveci pneumonia in AIDS patients: reactivation, reinfection or both?
    Hudson CP; Roach TC
    Int J STD AIDS; 2003 Sep; 14(9):644-5. PubMed ID: 14511507
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
    N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations.
    Gaut P; Daar ES
    Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888
    [No Abstract]   [Full Text] [Related]  

  • 12. Can I stop my PCP prophylaxis?
    Gaylord G
    Posit Living; 1999 Mar; 8(2):22. PubMed ID: 12492001
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS.
    Monforte AD; Mainini F; Bini T; Moscatelli GC; Antinori S; Formenti T; Testa L; Mena M; Moroni M
    J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
    Masur H
    Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prophylaxis against opportunistic infections in patients with AIDS.
    Clumeck N
    N Engl J Med; 1995 Mar; 332(11):739-40. PubMed ID: 7854383
    [No Abstract]   [Full Text] [Related]  

  • 16. Does the choice of Pneumocystis carinii prophylaxis influence the prevalence of Enterocytozoon bieneusi microsporidiosis in AIDS patients?
    Albrecht H; Sobottka I; Stellbrink HJ; Greten H
    AIDS; 1995 Mar; 9(3):302-3. PubMed ID: 7755923
    [No Abstract]   [Full Text] [Related]  

  • 17. Protect yourself from Pneumocystis carinii.
    AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Le Moal G; Breux JP; Roblot F
    N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 20. Polypharmacy: dangers of multiple-drug therapy in patients with immunodeficiency virus infection.
    Ungvarski P; Schmidt J
    Home Healthc Nurse; 1993; 11(2):68-9. PubMed ID: 8478201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.